questionsmedicales.fr
Composés chimiques organiques
Hydrocarbures
Terpènes
Monoterpènes
Cyclopentane monoterpenes
Pyréthrines
Alléthrine
Alléthrine : Questions médicales fréquentes
Termes MeSH sélectionnés :
Early Detection of Cancer
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Alléthrine : Questions médicales les plus fréquentes",
"headline": "Alléthrine : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Alléthrine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-14",
"dateModified": "2025-03-11",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Alléthrine"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Pyréthrines",
"url": "https://questionsmedicales.fr/mesh/D011722",
"about": {
"@type": "MedicalCondition",
"name": "Pyréthrines",
"code": {
"@type": "MedicalCode",
"code": "D011722",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.849.575.188.750"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Alléthrine",
"alternateName": "Allethrins",
"code": {
"@type": "MedicalCode",
"code": "D000487",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Pankaj Bhatt",
"url": "https://questionsmedicales.fr/author/Pankaj%20Bhatt",
"affiliation": {
"@type": "Organization",
"name": "State Key Laboratory for Conservation and Utilization of Subtropical Agro-bioresources, Guangdong Province Key Laboratory of Microbial Signals and Disease Control, Integrative Microbiology Research Centre, South China Agricultural University, Guangzhou 510642, China."
}
},
{
"@type": "Person",
"name": "Shaohua Chen",
"url": "https://questionsmedicales.fr/author/Shaohua%20Chen",
"affiliation": {
"@type": "Organization",
"name": "State Key Laboratory for Conservation and Utilization of Subtropical Agro-bioresources, Guangdong Province Key Laboratory of Microbial Signals and Disease Control, Integrative Microbiology Research Centre, South China Agricultural University, Guangzhou 510642, China."
}
},
{
"@type": "Person",
"name": "Yaohua Huang",
"url": "https://questionsmedicales.fr/author/Yaohua%20Huang",
"affiliation": {
"@type": "Organization",
"name": "State Key Laboratory for Conservation and Utilization of Subtropical Agro-bioresources, Guangdong Province Key Laboratory of Microbial Signals and Disease Control, Integrative Microbiology Research Centre, South China Agricultural University, Guangzhou 510642, China."
}
},
{
"@type": "Person",
"name": "Wenping Zhang",
"url": "https://questionsmedicales.fr/author/Wenping%20Zhang",
"affiliation": {
"@type": "Organization",
"name": "State Key Laboratory for Conservation and Utilization of Subtropical Agro-bioresources, Guangdong Province Key Laboratory of Microbial Signals and Disease Control, Integrative Microbiology Research Centre, South China Agricultural University, Guangzhou 510642, China."
}
},
{
"@type": "Person",
"name": "Eldon R Rene",
"url": "https://questionsmedicales.fr/author/Eldon%20R%20Rene",
"affiliation": {
"@type": "Organization",
"name": "Department of Environmental Engineering and Water Technology, IHE Delft Institute for Water Education, Westvest 7, 2601DA Delft, the Netherlands."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "DNA Methylation in the Fields of Prenatal Diagnosis and Early Detection of Cancers.",
"datePublished": "2023-07-20",
"url": "https://questionsmedicales.fr/article/37511475",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms241411715"
}
},
{
"@type": "ScholarlyArticle",
"name": "A Liquid Biopsy Signature for the Early Detection of Gastric Cancer in Patients.",
"datePublished": "2023-03-07",
"url": "https://questionsmedicales.fr/article/36894035",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1053/j.gastro.2023.02.044"
}
},
{
"@type": "ScholarlyArticle",
"name": "Early detection of cancer therapy cardiotoxicity by radionuclide angiography: An update.",
"datePublished": "2023-02-28",
"url": "https://questionsmedicales.fr/article/36855007",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12350-023-03202-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "Optimal age to stop prostate cancer screening and early detection.",
"datePublished": "2023-08-19",
"url": "https://questionsmedicales.fr/article/37598870",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jcpo.2023.100443"
}
},
{
"@type": "ScholarlyArticle",
"name": "Serum IgG N-glycans enable early detection and early relapse prediction of colorectal cancer.",
"datePublished": "2022-10-03",
"url": "https://questionsmedicales.fr/article/36121650",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/ijc.34298"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés chimiques organiques",
"item": "https://questionsmedicales.fr/mesh/D009930"
},
{
"@type": "ListItem",
"position": 3,
"name": "Hydrocarbures",
"item": "https://questionsmedicales.fr/mesh/D006838"
},
{
"@type": "ListItem",
"position": 4,
"name": "Terpènes",
"item": "https://questionsmedicales.fr/mesh/D013729"
},
{
"@type": "ListItem",
"position": 5,
"name": "Monoterpènes",
"item": "https://questionsmedicales.fr/mesh/D039821"
},
{
"@type": "ListItem",
"position": 6,
"name": "Cyclopentane monoterpenes",
"item": "https://questionsmedicales.fr/mesh/D000081004"
},
{
"@type": "ListItem",
"position": 7,
"name": "Pyréthrines",
"item": "https://questionsmedicales.fr/mesh/D011722"
},
{
"@type": "ListItem",
"position": 8,
"name": "Alléthrine",
"item": "https://questionsmedicales.fr/mesh/D000487"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Alléthrine - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Alléthrine",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-07",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Alléthrine",
"description": "Comment détecter une exposition à l'alléthrine ?\nQuels tests sont utilisés pour diagnostiquer une intoxication ?\nQuels symptômes indiquent une intoxication par l'alléthrine ?\nY a-t-il des signes cliniques spécifiques ?\nComment évaluer le niveau d'exposition ?",
"url": "https://questionsmedicales.fr/mesh/D000487?mesh_terms=Early+Detection+of+Cancer&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Alléthrine",
"description": "Quels sont les symptômes courants de l'alléthrine ?\nL'alléthrine provoque-t-elle des allergies ?\nPeut-on avoir des effets neurologiques ?\nQuels sont les effets à long terme ?\nLes enfants sont-ils plus sensibles ?",
"url": "https://questionsmedicales.fr/mesh/D000487?mesh_terms=Early+Detection+of+Cancer&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Alléthrine",
"description": "Comment prévenir l'exposition à l'alléthrine ?\nQuelles mesures de sécurité à prendre ?\nLes enfants doivent-ils être éloignés ?\nComment stocker l'alléthrine en toute sécurité ?\nDes alternatives à l'alléthrine existent-elles ?",
"url": "https://questionsmedicales.fr/mesh/D000487?mesh_terms=Early+Detection+of+Cancer&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Alléthrine",
"description": "Quel traitement pour une intoxication par l'alléthrine ?\nDes antidotes existent-ils pour l'alléthrine ?\nComment traiter les irritations cutanées ?\nQuand consulter un médecin après exposition ?\nY a-t-il des soins d'urgence nécessaires ?",
"url": "https://questionsmedicales.fr/mesh/D000487?mesh_terms=Early+Detection+of+Cancer&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Alléthrine",
"description": "Quelles complications peuvent survenir ?\nL'alléthrine peut-elle causer des maladies chroniques ?\nY a-t-il des risques pour les femmes enceintes ?\nDes effets sur la reproduction sont-ils possibles ?\nComment gérer les complications ?",
"url": "https://questionsmedicales.fr/mesh/D000487?mesh_terms=Early+Detection+of+Cancer&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Alléthrine",
"description": "Qui est le plus à risque d'intoxication ?\nLes personnes allergiques sont-elles plus vulnérables ?\nL'âge influence-t-il le risque d'exposition ?\nLes animaux domestiques sont-ils à risque ?\nY a-t-il des conditions médicales à risque ?",
"url": "https://questionsmedicales.fr/mesh/D000487?mesh_terms=Early+Detection+of+Cancer&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment détecter une exposition à l'alléthrine ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'exposition se détecte par des symptômes cliniques et des tests de laboratoire."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour diagnostiquer une intoxication ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analyses sanguines et urinaires peuvent être effectuées pour détecter des résidus."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une intoxication par l'alléthrine ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des maux de tête, des nausées et des irritations cutanées."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes cliniques spécifiques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des signes comme des troubles respiratoires peuvent survenir en cas d'exposition élevée."
}
},
{
"@type": "Question",
"name": "Comment évaluer le niveau d'exposition ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'évaluation se fait par l'historique d'exposition et des tests biologiques."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants de l'alléthrine ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent irritation des yeux, de la peau et des voies respiratoires."
}
},
{
"@type": "Question",
"name": "L'alléthrine provoque-t-elle des allergies ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines personnes peuvent développer des réactions allergiques à l'alléthrine."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des effets neurologiques ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des effets neurologiques comme des vertiges peuvent survenir en cas d'exposition élevée."
}
},
{
"@type": "Question",
"name": "Quels sont les effets à long terme ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une exposition prolongée peut entraîner des problèmes respiratoires chroniques."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus sensibles ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants peuvent être plus sensibles aux effets de l'alléthrine."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'exposition à l'alléthrine ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utilisez des insecticides avec précaution et suivez les instructions d'utilisation."
}
},
{
"@type": "Question",
"name": "Quelles mesures de sécurité à prendre ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Portez des gants et un masque lors de l'application d'alléthrine pour éviter l'exposition."
}
},
{
"@type": "Question",
"name": "Les enfants doivent-ils être éloignés ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, éloignez les enfants lors de l'application d'alléthrine pour éviter l'exposition."
}
},
{
"@type": "Question",
"name": "Comment stocker l'alléthrine en toute sécurité ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Conservez l'alléthrine dans un endroit frais, sec et hors de portée des enfants."
}
},
{
"@type": "Question",
"name": "Des alternatives à l'alléthrine existent-elles ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des insecticides naturels ou des méthodes de lutte intégrée peuvent être utilisées."
}
},
{
"@type": "Question",
"name": "Quel traitement pour une intoxication par l'alléthrine ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement inclut l'élimination de l'exposition et des soins symptomatiques."
}
},
{
"@type": "Question",
"name": "Des antidotes existent-ils pour l'alléthrine ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas d'antidote spécifique, le traitement est symptomatique."
}
},
{
"@type": "Question",
"name": "Comment traiter les irritations cutanées ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les irritations cutanées peuvent être traitées avec des crèmes apaisantes et des antihistaminiques."
}
},
{
"@type": "Question",
"name": "Quand consulter un médecin après exposition ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consultez un médecin si des symptômes graves ou persistants apparaissent."
}
},
{
"@type": "Question",
"name": "Y a-t-il des soins d'urgence nécessaires ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des soins d'urgence peuvent être nécessaires en cas de symptômes sévères ou d'exposition massive."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications respiratoires ou dermatologiques peuvent survenir après exposition."
}
},
{
"@type": "Question",
"name": "L'alléthrine peut-elle causer des maladies chroniques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une exposition prolongée peut contribuer à des maladies chroniques, notamment respiratoires."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques pour les femmes enceintes ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les femmes enceintes doivent éviter l'exposition à l'alléthrine en raison de risques potentiels."
}
},
{
"@type": "Question",
"name": "Des effets sur la reproduction sont-ils possibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent que l'exposition à l'alléthrine pourrait affecter la reproduction."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications doivent être gérées par des soins médicaux appropriés et un suivi régulier."
}
},
{
"@type": "Question",
"name": "Qui est le plus à risque d'intoxication ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les travailleurs agricoles et les personnes utilisant des insecticides à domicile sont à risque."
}
},
{
"@type": "Question",
"name": "Les personnes allergiques sont-elles plus vulnérables ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes ayant des antécédents d'allergies peuvent être plus vulnérables."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'exposition ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants et les personnes âgées sont plus sensibles aux effets de l'alléthrine."
}
},
{
"@type": "Question",
"name": "Les animaux domestiques sont-ils à risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les animaux domestiques peuvent également être affectés par l'exposition à l'alléthrine."
}
},
{
"@type": "Question",
"name": "Y a-t-il des conditions médicales à risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes ayant des problèmes respiratoires préexistants sont à risque accru."
}
}
]
}
]
}
The central objective of the metamorphosis of discovery science into biomedical applications is to serve the purpose of patients and curtail the global disease burden. The journey from the discovery o...
Diagnosing gastric cancer (GC) while the disease remains eligible for surgical resection is challenging. In view of this clinical challenge, novel and robust biomarkers for early detection thus improv...
The present 3-step study incorporated data from 2141 patients, including 888 with GC, 158 with chronic atrophic gastritis, 193 with intestinal metaplasia, 501 healthy donors, and 401 with other gastro...
In discovery phase, one LR (GClnc1) was found to be up-regulated in both tissue and circulating EV samples with an area under the curve (AUC) of 0.9369 (95% confidence interval [CI], 0.9073-0.9664) fo...
EV-derived GClnc1 serves as a circulating biomarker for the early detection of GC, thus providing opportunities for curative surgery and improved survival outcomes....
Cancer therapy-induced cardiotoxicity is an emerging clinical and healthcare issue. Myocardial dysfunction and heart failure are mostly responsible for increased cardiovascular mortality in cancer dis...
Prostate Cancer screening should be discontinued at older ages because competing mortality risks eventually dominate the risk of Prostate Cancer and harms exceed benefits. We explored the Prostate Can...
We applied Bellman Equations to formulate the net benefits biopsy and "do nothing". Using difference between the net benefits of two alternatives, we calculated the stopping age. The cancer states wer...
Our results suggested that Prostate Cancer screening stopping ages from the patient, healthcare system, and social were 70, 68, and 68 respectively. The univariate sensitivity analysis showed that the...
Men should not be screened for Prostate Cancer beyond 70 years old, as this results in the net benefit of "do nothing" above the biopsy. Nevertheless, this finding needs to be further studied with mor...
Colorectal cancer (CRC) develops mainly from colorectal advanced adenomas (AA), which are considered precancerous lesions. Novel early diagnostic biomarkers are urgently needed to distinguish CRC and ...
The modality to detect ovarian cancer at an early stage is very limited. Early diagnosis determines the prognosis. This study aimed to develop a risk assessment tool for early detection of ovarian can...
This study was carried out as a cohort study of patients diagnosed with suspected ovarian tumors undergoing cytoreduction operation at Hasan Sadikin Hospital, Bandung, from December 2019 to September ...
In total, 115 patients included in this study. The differences were statistically significant in terms of the six variables (abdominal bloating, nausea/vomiting, decreased of appetite, fullness, menst...
Risk assessments based on ovarian cancer self-assessment unfortunately were not comparable to postoperative histopathology as a single predictor. Ten variables in ovarian cancer artificial intelligenc...
Early detection of colorectal cancer (CRC) significantly enhances patient outcomes. Conventional CRC screening tools, like endoscopy and stool-based tests, have constraints due to their invasiveness o...
In this research, we harnessed the Mutation Capsule Plus (MCP) technology to profile an array of genomic characteristics from cfDNA procured from a single blood draw. This profiling encompassed DNA me...
This model was subsequently validated in another cohort comprising 89 CRC patients and 95 healthy controls. Remarkably, the model achieved an area under the curve (AUC) of 0.981 (95% confidence interv...
Our findings underscore the clinical potential of our multiomics liquid biopsy test, indicating its prospective role as a noninvasive method for early-stage CRC detection. This multiomics approach hol...
Clinical diagnostics rely heavily on the detection and quantification of cancer biomarkers. The rapid detection of cancer-specific biomarkers is of great importance in the early diagnosis of cancers a...
A cell-free DNA (cfDNA) assay would be a promising approach to early cancer diagnosis, especially for patients with dense tissues. Consistent cfDNA signatures have been observed for many carcinogens. ...
Hepatocellular carcinoma (HCC) is the fastest-rising and fourth most common cause of cancer death worldwide. Liver cirrhosis is the largest underlying risk factor for HCC. Therefore, patients with cir...
This is a UK-based prospective, longitudinal, diagnostic, prognostic, multicentre, non-CTIMP study. Aiming to recruit 3000 patients with liver cirrhosis without a HCC diagnosis, the Pearl cohort will ...
Ethical approval has been granted by REC and the trial is registered on ClinicalTrials.gov. The results will be published in peer-reviewed journals and presented at relevant meetings....
NCT05541601....